Your browser doesn't support javascript.
loading
Liquid formulation of ifosfamide increased risk of encephalopathy: A case-control study in a pediatric population.
Hillaire-Buys, Dominique; Mousset, Mégane; Allouchery, Marion; Azzouz, Brahim; Babin, Marina; Bellet, Florelle; Béné, Johana; Default, Anne; Durrieu, Geneviève; Géniaux, Hélène; Grandvuillemin, Aurélie; Gras-Champel, Valérie; Jantzem, Hélène; Lambert, Aude; Lepelley, Marion; Massy, Nathalie; Petitpain, Nadine; Rocher, Fanny; Sanchez-Pena, Paola; Sassier, Marion; Simon, Corinne; Triquet, Louise; Valnet-Rabier, Marie-Blanche; Veyrac, Gwenaëlle; Faillie, Jean-Luc; Zenut, Marie-Christine.
Afiliação
  • Hillaire-Buys D; Department of medical pharmacology and toxicology, CRPV, CHU de Montpellier, 371, avenue Doyen-Giraud, 34295 Montpellier, France. Electronic address: d-hillaire@chu-montpellier.fr.
  • Mousset M; Department of medical pharmacology and toxicology, CRPV, CHU de Montpellier, 371, avenue Doyen-Giraud, 34295 Montpellier, France.
  • Allouchery M; Department of clinical pharmacology and vigilances, CPRV, CHU de Poitiers, 86021 Poitiers, France.
  • Azzouz B; Department of pharmacovigilance and pharmacoepidemiology, CRPV, CHU de Reims, 51092 Reims, France.
  • Babin M; Department of pharmacology and toxicologie, CRPV, CHU d'Angers, 49933 Angers, France.
  • Bellet F; Department of pharmacovigilance, CRPV, CHU de Saint-Étienne, 42055 Saint-Étienne, France.
  • Béné J; Department of pharmacovigilance, CRPV, CHU de Lille, 59045 Lille, France.
  • Default A; Department of clinical pharmacology, CRPV, Sainte-Margueritte hospital, AP-AHM, 13274 Marseille, France.
  • Durrieu G; Department of clinical pharmacology, CRPV, CHU de Toulouse, 31000 Toulouse, France.
  • Géniaux H; Department of pharmacology, toxicology and pharmacovigilance, CRPV, CHU de Limoges, 87000 Limoges, France.
  • Grandvuillemin A; Department of vigilances, CRPV, CHU de Dijon, 21079 Dijon, France.
  • Gras-Champel V; Department of human biology, CRPV, CHU d'Amiens-Picardie, 80054 Amiens, France.
  • Jantzem H; Department of pharmacovigilance, CRPV, CHU de Brest, 29609 Brest, France.
  • Lambert A; Department of pharmaocvigilance, CRPV, Civil hospital of Strasbourg, 67091 Strasbourg, France.
  • Lepelley M; Department of public health, CRPV, CHU Grenoble-Alpes, 38700 Grenoble, France.
  • Massy N; Department of clinical biology, CRPV, CHU de Rouen, 76031 Rouen, France.
  • Petitpain N; Department of clinical pharmacology and toxicology, CRPV, CHU de Nancy, 54511 Nancy, France.
  • Rocher F; Department of pharmacovigilance, CRPV, Cimiez hospital, CHU de Nice, 06003 Nice, France.
  • Sanchez-Pena P; Department of medical pharmacology, CRPV, Pellegrin hospital, CHU de Bordeaux, 33300 Bordeaux, France.
  • Sassier M; Department of pharmacology, CRPV, CHU de Caen, 14000 Caen, France.
  • Simon C; Department of pharmacosurveillance, CRPV, CHU de Tours, 37044 Tours, France.
  • Triquet L; Department of clinical pharmacology and biology, CRPV, Pontchaillou hospital, CHU de Rennes, 35033 Rennes, France.
  • Valnet-Rabier MB; Department of pharmacovigilance, CRPV, CHU de Besançon, 25030 Besançon, France.
  • Veyrac G; Department of clinical pharmacology, CRPV, CHU de Nantes, 44093 Nantes, France.
  • Faillie JL; Department of medical pharmacology and toxicology, CRPV, CHU de Montpellier, 371, avenue Doyen-Giraud, 34295 Montpellier, France.
  • Zenut MC; Department of medical pharmacology, CRPV, CHU de Clermont-Ferrand,63003 Clermont-Ferrand, France.
Therapie ; 75(5): 471-480, 2020.
Article em En | MEDLINE | ID: mdl-31732241

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encefalopatias / Ifosfamida Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Therapie Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encefalopatias / Ifosfamida Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Therapie Ano de publicação: 2020 Tipo de documento: Article